Innoviva to participate in upcoming investor conferences
Innoviva says it will participate in upcoming investor conferences. The company describes its diversified biopharmaceutical focus, including a royalties portfolio and critical care and infectious disease platform.
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare asse…